Gramicidin, also called gramicidin D, is a mix of ionophore antibiotics, gramicidin A, B and C, which make up about 80%, 5%, and 15% of the mix, respectively. Each has 2 isoforms, so the mix has 6 different types of gramicidin molecules. They can be extracted from Brevibacillus brevis soil bacteria. Gramicidins are linear with 15 amino acids. This is in contrast to unrelated gramicidin S, which is a cyclic peptide.
Gramicidins are used in medicinal Throat lozenge for sore throat and in topical medicines to treat infected wounds. Gramicidins are often mixed with other antibiotics like tyrocidine and antiseptics. Gramicidins are also used in eye drops for bacterial eye infections. In drops, they are often mixed with other antibiotics like polymyxin B or neomycin. Multiple antibiotics increase efficiency against various strains of bacteria. Such eye-drops are also used to treat eye infections of animals, like horses.
In 1964, the sequence of gramicidin A was determined by Reinhard Sarges and Bernhad Witkop.
In 1971, the dimeric head-to-head structure of gramicidins was proposed by D. W. Urry.
In 1993, the structure of the gramicidin head-to-head dimer in micelles and was determined by solution and solid-state NMR.
Gramicidin mixture is a crystalline solid. Its solubility in water is minimal, 6 mg/L, and it may form suspensions. It is soluble in small alcohols, acetic acid, pyridine, poorly soluble in acetone and dioxane, and practically insoluble in diethylether and hydrocarbons.
Gramicidins can be used as topical antibiotic medications in low doses, even though they are potentially lethal for human cells. Bacteria die at lower gramicidin concentrations than human cells. Gramicidins are not used internally, as their significant intake may cause hemolysis and be toxic to the liver, kidney, meninges and olfactory system among other effects.
|
|